Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.

NFC Skin Patches

From the National Labs to Hospitals and Homes

Radar Responsive Tag, a sophisticated geolocation and tracking technology, is capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips, combined with sensors, are capable of providing exquisite location services.

Advanced Geolocation

This is a text block. Click the edit button to change this text.

Working to reduce costly hospital readmissions

By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.

Discharge Kits

  • Gentag’s Wearable Diagnostic Skin Patch Patents Receive Notice of Allowance from the European Patent Office

    August 5, 2014

    WASHINGTON, DC, August 5, 2014 – Gentag, Inc. is pleased to announce that it has been granted additional allowances for its patents in Europe, which will greatly enhance the company’s already significant intellectual property holdings of near field communication (NFC) sensor technologies related to wearable biosensors, body-area-networks (BAN), sensor diagnostics and advanced geolocation. Gentag’s patents address the uses of disposable diagnostic NFC devices, including skin patches and associated readers in cell phones, and will issue in thirty countries including Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Germany, Estonia, Finland, France, Greece, Hungary, Ireland, Iceland, Italy, Liechtenstein, Lithuania, Luxembourg,...

    Read more
    5